Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Gastroenterology
|
August 1, 1995
Undifferentiated carcinoma of the duodenal ampulla
T Sato, K Yamamoto, A Ouchi, et al.
Oncology
|
September 1, 1994
Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas
T Takada, H Kato, T Matsushiro, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
April 1, 1991
[Cell kinetic studies on the gallbladder epithelium in patient with anomalous arrangement of pancreatobiliary duct]
H Yoshioka, K Koyama, Y Sato, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
December 1, 1980
[Factors influencing the cholesterol dissolution ability in human bile (author's transl)]
T Matsushiro, H Cho, H Nagashima, et al.
The Tohoku Journal of Experimental Medicine
|
August 1, 1984
Exfoliation as a mode of cancer elimination in rectal carcinoma
S Okuyama, H Mishina, T Hariu, et al.
The Tohoku Journal of Experimental Medicine
|
September 1, 1981
Factors affecting the cholesterol dissolution ability of human bile
T Matsushiro, H Cho, H Nagashima, et al.
Hepato-Gastroenterology
|
February 10, 1999
Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial
T Takada, Y Nimura, H Katoh, et al.
American Journal of Surgery
|
September 1, 1986
Valvuloplasty plus fundoplasty to prevent esophageal regurgitation in esophagogastrostomy after proximal gastrectomy
T Matsushiro, T Hariu, H Nagashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 24, 2001
[Home anti-cancer therapy with a venous port]
A Muto, Y Ashino, M Miyazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]
T Takada, H Kato, M Sasaki, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Gastroenterology
|
August 1, 1995
Undifferentiated carcinoma of the duodenal ampulla
T Sato, K Yamamoto, A Ouchi, et al.
Oncology
|
September 1, 1994
Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas
T Takada, H Kato, T Matsushiro, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
April 1, 1991
[Cell kinetic studies on the gallbladder epithelium in patient with anomalous arrangement of pancreatobiliary duct]
H Yoshioka, K Koyama, Y Sato, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
December 1, 1980
[Factors influencing the cholesterol dissolution ability in human bile (author's transl)]
T Matsushiro, H Cho, H Nagashima, et al.
The Tohoku Journal of Experimental Medicine
|
August 1, 1984
Exfoliation as a mode of cancer elimination in rectal carcinoma
S Okuyama, H Mishina, T Hariu, et al.
The Tohoku Journal of Experimental Medicine
|
September 1, 1981
Factors affecting the cholesterol dissolution ability of human bile
T Matsushiro, H Cho, H Nagashima, et al.
Hepato-Gastroenterology
|
February 10, 1999
Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial
T Takada, Y Nimura, H Katoh, et al.
American Journal of Surgery
|
September 1, 1986
Valvuloplasty plus fundoplasty to prevent esophageal regurgitation in esophagogastrostomy after proximal gastrectomy
T Matsushiro, T Hariu, H Nagashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 24, 2001
[Home anti-cancer therapy with a venous port]
A Muto, Y Ashino, M Miyazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 1, 1992
[Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]
T Takada, H Kato, M Sasaki, et al.
Page
of 5